Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AVEO Pharmaceuticals, Inc.
Scientific Title
A Phase 3, Randomized, Controlled, Multicenter, Open-label Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma Who Have Progressed Following One or Two Lines of Therapy Where One Line Has an Immune Checkpoint Inhibitor